查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1840876

脑图谱仪器- 全球预测（2025-2032 年）

Brain Mapping Instruments Market by Component, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，脑图谱仪器市场规模将达到 51.5 亿美元，复合年增长率为 14.37%。

关键市场统计数据
基准年 2024 17.5亿美元
预计年份：2025年 20.1亿美元
预测年份 2032 51.5亿美元
复合年增长率 (%) 14.37%

全面介绍不断发展的脑图谱仪器生态系统，包括硬体、服务、软体和终端用户互通性

脑图谱仪器在神经科学研究、临床诊断和治疗创新领域中发挥着至关重要的作用。目前的研究设备涵盖了由硬体、服务和软体组成的复杂生态系统，这些组件共同作用，使临床医生和研究人员能够可视化、量化和解读跨越多个时空尺度的神经活动。随着技术能力的不断提升，这些设备日益成为多模态整合、进阶分析和协作工作流程的平台，其应用范围已超越了单一设备部署。

硬体层包括分析仪、电极、感测器和扫描系统，这些设备必须具备高精度、高可靠性，并与不断发展的分析流程相容。咨询、维护和培训等支援服务透过确保营运的连续性和最大化科研产量，为成功实施奠定了基础。软体解决方案涵盖从分析应用程式到资料管理系统的各种应用，旨在将高维度讯号转换为可重复的、符合监管要求的输出结果。

临床和研究领域的使用者需求多种多样，但又相互关联。神经病学、肿瘤学和精神病学需要仪器来辅助诊断和治疗监测，而学术研究、认知神经科学和药物研究则需要灵活的平台来进行假设驱动的实验和转化研究。最终用户，包括学术和研究机构、医院、诊断中心以及製药和生物技术公司，各自有不同的采购週期、监管要求和资料管治要求。

综上所述，这些动态凸显了仪器发展方向的转变，即从单一功能仪器转向可互通、软体驱动的系统转变，后者优先考虑资料完整性和生命週期支援。本引言为深入分析技术发展轨迹、供应链压力、监管考量以及策略性倡议奠定了基础，这些因素将决定哪些解决方案能够产生临床和商业性影响。

深入探讨技术融合、资料优先平台和服务主导模式如何推动脑图谱仪器在临床和研究领域的应用。

小型化、即时分析和人性化的设计技术的进步，正在拓展神经数据的采集地点和方式，从而改变脑图谱仪器的模式。可携式和无线脑电图（EEG）系统使研究能够在传统实验室环境之外进行，重新定义了可及性；而可穿戴式脑磁图（MEG）和新兴的近红外光谱（NIRS）技术则降低了长期和动态监测的变革时期。这些硬体创新，结合云端原生资料架构和边缘分析技术，正在开启情境神经科学的新时代，在这个时代，以患者和参与者为中心的工作流程将得以大规模实现。

同时，软体正从孤立的分析软体套件演变为融合了先进讯号处理、机器学习和安全资料管理的整合平台。分析软体如今更加重视可復现性、溯源性和合规性，而资料管理系统则需适应更严格的隐私权保护要求和联邦学习模型。因此，咨询、维护和培训等服务也日益专注于帮助科研机构运作复杂的仪器设备群，并从高频资料流中获得长期价值。

另一个显着的变化是临床与研究之间的界线日益模糊。临床和研究用途的功能性磁振造影（fMRI）工作流程正透过标准化通讯协定和可互通的资料格式逐渐融合，而正子断层扫描（PET）成像的各种亚型也被整合到多模态研究中，将代谢讯号与电生理和血流动力学测量结果关联起来。这种融合促进了医院、学术中心和製药公司之间更深入的合作，加速了实验结果转化为诊断和治疗工具的发展。

最后，监管和报销压力正在影响产品蓝图。製造商优先考虑那些能够展现临床效用并符合支付方和监管机构所采用的证据框架的功能。同时，随着地缘政治因素影响采购和生产决策，供应链韧性和在地化策略变得至关重要。这些因素的综合作用正在重新定义竞争优势，使企业能够凭藉卓越的设备、强大的软体生态系统和端到端的服务能力脱颖而出。

对近期贸易政策和关税变化如何改变脑图谱系统中的供应链选择、采购模式和服务优先事项进行深入分析

关税制度和贸易政策的变化会对脑成像生态系统产生连锁反应，影响关键组件和完整系统的供应、前置作业时间和成本结构。如果对进口电子产品、感测器和成像子系统征收关税，製造商和采购团队将被迫重新评估其供应链，并考虑其他方案以降低进口成本增加的风险。这通常会加速供应商多元化、组件生产近岸化以及增加库存缓衝等的考量，以确保临床和研究客户的业务连续性。

2025年关税调整的累积影响凸显了製造布局和供应商关係的策略重要性。拥有垂直整合能力或本地组装设施的供应商将具有相对优势，因为他们可以帮助买家规避运输相关的不确定性和与海关相关的波动。医院和研究机构通常资金周转和采购週期较短，它们可能会调整采购模式，倾向于选择模组化系统，以便进行逐步升级而非全面更换，从而降低进口关税上涨带来的价格敏感度。

关税也在刺激合约和服务模式的变革。随着零件成本的上涨，资本支出的合理性论证变得越来越复杂，许多机构将探索基于服务的采购、延长租赁协议以及平台即服务 (PaaS) 等方案，以便在无需承担全部前期成本的情况下继续使用尖端仪器。能够提供全面的维护、培训和以结果为导向的服务包的供应商，将更有利于留住那些能够承受关税主导的预算限制的机构客户。

最后，监管和合规工作与关税主导的策略选择相互交织。寻求本地化供应的机构可能会在不同司法管辖区遇到不同的监管路径和检验要求。因此，医疗机构必须儘早投资于监管策略和设计控制措施，以确保供应商或生产地点的变更不会损害临床有效性或研究完整性。总体而言，关税动态正在推动供应链向敏捷性、服务主导交付和在地化验证工作转变，这些因素共同影响采购和研发的优先事项。

透过对组件、技术、应用和最终用户的细分洞察，揭示了不同的市场采纳驱动因素和产品开发重点。

组件级细分揭示了硬体、服务和软体各自不同的价值驱动因素。硬体投资优先考虑分析仪的准确性和可靠性、电极和感测器的灵敏度和生物相容性，以及扫描仪的吞吐量和影像保真度。咨询、维护和培训等服务是差异化因素，能够降低整体拥有成本，并缩短临床人员和研究团队的熟练时间。软体分为支援科学解读的分析应用程式和确保安全、可扩展储存以及符合监管要求的审核追踪的资料管理解决方案。

科技碎片化凸显了创新和应用压力最大的领域。脑电图（EEG）技术，包括携带式、固定式和无线式等多种形式，正引领传统中心以外的资料撷取普及化。功能性磁振造影（fMRI）作为一种高解析度成像方式，继续发挥其在临床和研究工作流程中的作用；脑磁图（MEG）技术则透过头盔式系统和新兴的可穿戴式设备不断发展，降低了长期监测的门槛。近红外光谱（NIRS）技术（包括连续波、频域和时域成像）提供了互补的血流动力学信息，儘管它们在空间分辨率和深度灵敏度之间存在不同的权衡。正子断层扫描（PET）成像，包括淀粉样蛋白PET、FDG-PET和Tau蛋白PET，持续提供分子特异性讯息，这与神经退化疾病研究和肿瘤学应用密切相关。

应用细分区分了临床和研究需求。神经病学、肿瘤学和精神病学等临床应用需要检验、可重复的输出结果，并将其整合到诊断流程和治疗监测中。学术研究、认知神经科学和药物研究等研究应用则需要灵活的实验设计平台、高通量资料收集以及严格的溯源机制以确保结果的可重复性。最终用户细分则阐明了应用采用的动态：学术研究机构优先考虑灵活性和新功能；医院和诊断中心重视可靠性、合规性和临床医生工作流程；而製药和生物技术公司则重视转化应用的稳健性和数据互通性，以支持其药物开发平臺。

这些细分视角为相关人员提供了一个框架，使他们能够将产品蓝图、服务产品和打入市场策略与每项技术、应用和使用者群体的独特需求保持一致。

美洲、欧洲、中东和非洲以及亚太地区的竞争和招募动态对采购、製造和合作研究策略产生影响。

区域动态对脑图谱仪器的研发、应用和商业化有显着影响，每个主要区域都各具特色，既有优势也有限制因素。在美洲，完善的临床基础设施和集中的生物技术及製药活动催生了对先进成像和电生理解决方案的需求，而充满活力的研究生态系统则促进了快速的转化合作。该地区还拥有成熟的製造群和创业投资网络，为创新提供支持，但公共医疗系统的采购週期可能较长。

欧洲、中东和非洲呈现出多元化的格局，严格的监管环境和强大的公共医疗体係有利于采用经过验证的临床工具和整合式服务。欧洲许多地区的卓越学术水平支持深入的研究伙伴关係和先进检验调查方法的标准化，而更广泛区域内的新兴中心正日益成为本地製造和提供经济高效、性能可靠的设备的重要市场，以支持不断扩展的诊断能力。

亚太地区正经历可携式和扩充性技术的快速普及，同时本地製造能力不断提升，政府也大力支持数位医疗和医疗设备创新。大规模生产的医疗保健市场和不断增长的研发投入，为兼顾成本效益的医疗器材策略和支援大规模研究的高端数据平台创造了机会。根据不同地区的具体情况，当地政策、报销机制和人才储备将影响新技术从早期应用到常规临床应用的速度，而这些因素也将影响产品组合、定价和售后服务模式等方面的策略决策。

公司策略和竞争优势专注于模组化硬体、高级分析、整合服务以及能够推动设施长期采用的伙伴关係关係。

脑图谱仪器领域的公司在多个方面实现差异化：模组化硬体、先进的软体和全面的服务。领先的设备製造商专注于感测器性能、讯号保真度和符合人体工学的设计，以缩短设定时间并支援不同的研究人群。同时，以软体为中心的供应商则强调可復现的流程、可解释的机器学习和可互通的资料标准，以促进与电子健康记录和实验室系统的整合。

服务供应商正透过将咨询、验证和培训与长期维护合约捆绑在一起，强化​​提案，从而围绕执行时间和数据品质建立奖励。设备製造商与云端和分析公司之间的合作日益普遍，反映出企业正朝着以平台为中心的经营模式发展。新兴企业经常推出颠覆性的硬体概念或专业分析技术，而现有企业则透过有针对性的收购、策略联盟或加速内部互补能力的开发来应对。

投资人的关注和企业发展活动往往倾向于那些展现出监管敏锐度并能提供临床或转化价值证据的公司。能够展现出强大的数据管治框架、完善的临床合作伙伴生态系统以及涵盖资本销售到订阅服务的灵活交付模式的公司，更有利于获取多方相关人员的价值。最后，卓越的製造营运、供应链韧性和客户支援往往决定客户维繫，尤其是在服务连续性至关重要的临床和诊断领域。

针对领导者可采取的行动建议，以加强供应链、投资数据平台并建立协作证据路径，从而促进临床应用的持续发展。

为因应地缘政治和关税波动，产业领导者应优先考虑供应链韧性和模组化产品设计，以确保为临床和科学研究客户提供持续服务。投资本地组装和建立策略供应商合作伙伴关係可以减少前置作业时间波动，并保护医疗机构免受突发成本衝击。

领导者还必须加快对资料管理和分析平台的投资，以支援监管可追溯性和互通性工作流程。重视可復现的分析流程、追溯追踪和隐私保护资料策略，将有助于与临床应用和药物研发专案开展合作。结合有针对性的服务，例如现场培训、远端维护和以结果为导向的咨询，这些能力可以将业务关係转化为策略性的长期合作关係。

与学术中心和临床领导者进行策略合作至关重要，这有助于获得临床效用证据，并共同製定符合支付方和监管机构期望的方案。企业应探索灵活的商业模式，例如基于订阅的准入和基于绩效的定价，以降低资金紧张的诊所采用该技术的门槛。最后，制定一项重点突出、能够预见跨司法管辖区检验要求的监管策略，将加快产品部署并最大限度地减少返工，尤其对于计划本地化生产或进入新地域市场的公司而言更是如此。

采用严谨的混合调查方法，结合相关人员访谈、监管机构调查和技术调查，以获得可操作、可复製的洞见。

本执行执行摘要的调查方法融合了定性和结构化的证据收集技术，以确保其稳健性和有效性。主要研究包括对临床医生、首席研究员、采购负责人和设备工程师进行深度访谈，以了解操作实务、痛点和应用标准。此外，还对监管指南、技术标准和同行评审文献进行了系统性回顾，以梳理检验路径、安全考量和最佳方法实践。

分析过程包括针对特定技术的应用映射，以匹配设备功能与临床和研究需求；以及供应链映射，以识别采购风险和缓解措施。从最终用户、製造商和服务供应商的观点进行三角验证，有助于检验结论并确保建议反映实际情况的限制。当新出现的证据或区域差异影响结论的普遍适用性时，我们会谨慎地记录假设并揭露局限性。

本研究的资料管治优先考虑可追溯性和可重现性，并制定了结构化的访谈主题编码和原始资讯归檔通讯协定。在定量输入有助于解读情境的情况下，我们采取保守且透明的方法，避免过度强调确定性。总体而言，该方法旨在平衡深刻见解与临床、研究和商业决策者的实际应用价值。

简明结论总结了技术创新、服务模式和供应链动态的相互作用将如何塑造脑图谱仪器。

脑图谱仪器的发展轨迹呈现出快速的技术创新、不断演进的服务模式以及不断变化的供应链格局，这既为相关人员带来了机会，也带来了挑战。无论是硬体、软体或服务，成功越来越依赖提供可互通、以数据为中心的解决方案，这些方案既要符合监管和临床工作流程，又要为实际部署提供清晰的路径。应用模式反映了高保真成像技术和新兴可携式技术之间的相互作用，而最成功的策略是将这些技术整合到灵活且有实证基础的产品中。

区域和政策动态，包括贸易政策调整，凸显了供应链敏捷性、在地检验和服务主导商业模式的重要性。积极透过模组化设计、资料管理投资和协作式证据产生来应对这些挑战的研发机构，将能更好地满足学术研究人员、临床团队和药物研发人员的多元化需求。总之，最具韧性和影响力的公司，将是那些将卓越的技术能力与强大的支持体系和策略伙伴关係关係相结合，从而加速研究成果实用化的公司。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 可携式脑电图系统在远端神经系统诊断和持续病患监测的应用日益广泛
  • 将人工智慧演算法与神经影像数据结合，以提高脑图谱绘製的准确性和预测分析能力。
  • 利用功能性近红外线光谱技术开发用于临床研究的可穿戴式脑监测设备
  • 扩展云端基础的神经数据平台，以支援神经科学研究中的即时协作和巨量资料分析
  • 监管核准和报销框架，以推进医院诊断性脑图谱仪器的商业化
  • 消费级脑电图头戴装置的兴起，使得认知能力分析和神经回馈变得轻而易举。
  • 结合脑电图、脑磁图和磁振造影的多模态脑造影技术取得了进展，提高了研究中的时空解析度。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章脑图谱仪器市场（按组件划分）

  • 硬体
    • 分析设备
    • 电极和感测器
    • 扫描器
  • 服务
    • 咨询
    • 维护和培训
  • 软体
    • 分析软体
    • 资料管理软体

第九章脑图谱仪器市场（依技术划分）

  • EEG
    • 可携式脑电图系统
    • 固定式脑电图系统
    • 无线脑电图系统
  • fMRI
    • 临床功能性磁振造影
    • 研究功能性磁振造影
  • MEG
    • 头盔式MEG
    • 穿戴式 MEG
  • NIRS
    • 连续波近红外光谱
    • 频域近红外光谱
    • 时域近红外光谱
  • PET
    • 淀粉样蛋白PET
    • FDG-PET
    • Tau PET

第十章脑图谱仪器市场（依应用领域划分）

  • 临床
    • 神经病学
    • 肿瘤学
    • 精神病学
  • 研究
    • 学术研究
    • 认知神经科学
    • 药物研究

第十一章脑图谱仪器市场（依最终用户划分）

  • 学术研究机构
  • 医院和诊断中心
  • 製药和生物技术公司

第十二章脑图谱仪器市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章脑图谱仪器市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国脑图谱仪器市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Advanced Brain Monitoring, Inc
    • Brainlab AG
    • Siemens Healthineers AG
    • Shimadzu Corporation
    • Nihon Kohden Corporation
    • Medtronic PLC
    • SCANCO Medical AG
    • Koninklijke Philips NV
    • Cognionics, Inc.
    • GE Healthcare
Product Code: MRR-2214614772D1

The Brain Mapping Instruments Market is projected to grow by USD 5.15 billion at a CAGR of 14.37% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.75 billion
Estimated Year [2025] USD 2.01 billion
Forecast Year [2032] USD 5.15 billion
CAGR (%) 14.37%

A comprehensive introduction to the evolving ecosystem of brain mapping instruments addressing hardware, services, software, and end user interoperability

Brain mapping instruments occupy a pivotal role at the intersection of neuroscience research, clinical diagnostics, and therapeutic innovation. Contemporary instruments span a complex ecosystem of hardware, services, and software that together enable clinicians and researchers to visualize, quantify, and interpret neural activity across multiple spatial and temporal scales. As technological capabilities expand, instruments increasingly serve as platforms for multimodal integration, advanced analytics, and collaborative workflows that extend beyond isolated device deployment.

The hardware layer encompasses analysis equipment, electrodes and sensors, and scanning systems that must deliver precision, reliability, and compatibility with evolving analytical pipelines. Supporting services, including consulting and maintenance plus training programs, underpin successful adoption by ensuring operational continuity and maximized scientific yield. Software solutions range from analysis applications to data management systems designed to turn high-dimensional signals into reproducible, regulatory-grade outputs.

Across clinical and research contexts, user needs diverge but remain interconnected. Neurology, oncology, and psychiatry demand instruments that support diagnostic clarity and therapeutic monitoring, while academic research, cognitive neuroscience, and pharmaceutical research require flexible platforms for hypothesis-driven experimentation and translational studies. End users such as academic and research institutes, hospitals and diagnostic centers, and pharmaceutical and biotechnology companies each bring distinct procurement cycles, regulatory expectations, and data governance requirements.

Taken together, these dynamics underscore a shift from single-function devices toward interoperable, software-enabled systems that prioritize data integrity and lifecycle support. The introductory framing here sets the stage for deeper analysis of technology trajectories, supply chain pressures, regulatory considerations, and the strategic moves that will determine which solutions realize clinical and commercial impact.

An in-depth exploration of technological convergence, data-first platforms, and service-driven models reshaping brain mapping instrument adoption across clinical and research settings

The landscape for brain mapping instruments is undergoing transformative shifts driven by advances in miniaturization, real-time analytics, and human-centered design that expand where and how neural data can be collected. Portable and wireless EEG systems have redefined accessibility by enabling studies outside of traditional lab environments, while wearable magnetoencephalography and novel NIRS modalities are reducing barriers to longitudinal and ambulatory monitoring. These hardware innovations, paired with cloud-native data architectures and edge analytics, are ushering in a new era of contextual neuroscience where patient- and participant-centric workflows become feasible at scale.

Simultaneously, software is evolving from isolated analysis packages toward integrated platforms that combine advanced signal processing, machine learning, and secure data management. Analysis software now emphasizes reproducibility, provenance tracking, and regulatory readiness, and data management systems are adapting to stricter privacy expectations and federated learning models. As a result, services such as consulting, maintenance, and training increasingly focus on enabling institutions to operationalize complex instrument fleets and to extract longitudinal value from high-frequency data streams.

Another notable shift is the blurring of boundaries between clinical and research applications. Clinical fMRI and research fMRI workflows are converging through standardized protocols and interoperable data formats, while PET imaging subtypes are being integrated into multimodal studies that correlate metabolic signals with electrophysiological and hemodynamic measures. This convergence is fostering deeper collaborations between hospitals, academic centers, and pharmaceutical organizations, and it is accelerating the translation of experimental findings into diagnostic and therapeutic tools.

Finally, regulatory and reimbursement pressures are shaping product roadmaps. Manufacturers are prioritizing features that demonstrate clinical utility and that align with evidence frameworks used by payers and regulators. In parallel, supply chain resilience and localization strategies are becoming essential as geopolitical considerations influence sourcing and production decisions. Together, these shifts are redefining competitive advantage, moving it toward those organizations that combine device excellence with robust software ecosystems and end-to-end service capabilities.

A detailed analysis of how recent changes to trade policy and tariffs have altered supply chain choices, procurement models, and service priorities in brain mapping systems

Changes to tariff regimes and trade policy can ripple through the brain mapping ecosystem by affecting the availability, lead times, and cost profiles of critical components and finished systems. In scenarios where tariffs are applied to imported electronics, sensors, and imaging subsystems, manufacturers and procurement teams face pressure to reassess supply chains and to consider alternatives that reduce exposure to increased import costs. This often prompts accelerated conversations about supplier diversification, nearshoring of component production, and increased inventory buffering to ensure continuity for clinical and research customers.

The cumulative impact of tariff shifts in 2025 has been to elevate the strategic importance of manufacturing footprint and supplier relationships. Suppliers with vertically integrated capabilities or localized assembly facilities gain relative advantages because they can shield buyers from transit-related uncertainty and customs-related variability. Hospitals and research institutes, which typically operate on tight capital and procurement cycles, may adjust purchasing patterns to prioritize modular systems that allow incremental upgrades rather than full system replacements, thereby mitigating the price sensitivity introduced by higher import duties.

Tariffs also stimulate changes in contracting and service models. As capital expenditures become more complex to justify under higher component costs, many organizations will explore service-based procurement, extended leasing arrangements, and platform-as-a-service options to maintain access to leading-edge instrumentation without bearing the full upfront cost. Vendors that can provide comprehensive maintenance, training, and outcome-oriented service bundles are better positioned to retain institutional customers navigating tariff-driven budgetary constraints.

Lastly, regulatory and compliance efforts intersect with tariff-driven strategic choices. Institutions seeking to localize supply may encounter differing regulatory pathways and validation requirements across jurisdictions. Therefore, organizations must invest early in regulatory strategy and design controls to ensure that any changes in supplier or manufacturing location do not compromise clinical validity or research integrity. Overall, tariff dynamics are prompting a reorientation toward supply chain agility, service-led offerings, and localized validation efforts that collectively shape procurement and development priorities.

Targeted segmentation insights across components, technologies, applications, and end users that reveal differentiated adoption drivers and product development priorities

Component-level segmentation reveals divergent value drivers across hardware, services, and software. Hardware investments prioritize the precision and reliability of analysis equipment, the sensitivity and biocompatibility of electrodes and sensors, and the throughput and image fidelity of scanners. Services such as consulting and maintenance plus training become differentiators that reduce total cost of ownership and accelerate time-to-proficiency for clinical staff and research teams. Software divides into analysis applications that underpin scientific interpretation and data management solutions that ensure secure, scalable storage and regulatory-ready audit trails.

Technology segmentation clarifies where innovation and adoption pressures are most acute. EEG technologies, in their portable, stationary, and wireless forms, lead in democratizing data collection outside of traditional centers. fMRI retains its role as a high-resolution modality with distinct clinical and research workflows, while MEG is evolving through both helmet-based systems and emerging wearable formats that lower barriers to longitudinal monitoring. NIRS technologies-continuous wave, frequency domain, and time domain-offer complementary hemodynamic insights with varying trade-offs in spatial resolution and depth sensitivity. PET imaging, including amyloid PET, FDG-PET, and tau PET, continues to provide molecular specificity that intersects with neurodegenerative research and oncology applications.

Application segmentation differentiates clinical needs from research imperatives. Clinical deployments in neurology, oncology, and psychiatry demand validated, reproducible outputs that integrate into diagnostic pathways and therapeutic monitoring. Research applications across academic research, cognitive neuroscience, and pharmaceutical research require flexible platforms for experimental design, high-throughput data capture, and rigorous provenance for reproducibility. End-user segmentation underscores adoption dynamics: academic and research institutes prioritize flexibility and novel capabilities; hospitals and diagnostic centers emphasize reliability, regulatory compliance, and clinician workflows; and pharmaceutical and biotechnology companies focus on translational robustness and data interoperability for drug development pipelines.

Together, these segmentation lenses provide a framework for stakeholders to align product roadmaps, service offerings, and go-to-market strategies with the distinct needs of each technology, application, and user constituency.

Regional competitive and adoption dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence procurement, manufacturing, and research collaboration strategies

Regional dynamics exert a powerful influence on the development, adoption, and commercialization of brain mapping instruments, with distinct strengths and constraints characterizing each major geography. In the Americas, robust clinical infrastructure and concentrated biotech and pharmaceutical activity create demand for sophisticated imaging and electrophysiology solutions, while a vibrant research ecosystem fosters rapid translational collaborations. This region also features established manufacturing clusters and venture capital networks that support innovation, though procurement cycles in public health systems can be lengthy.

Europe, Middle East & Africa presents a diverse landscape where regulatory rigor and strong public healthcare systems drive a preference for validated clinical tools and integrated service offerings. Academic excellence across many European centers sustains deep research partnerships and high levels of methodological standardization. Meanwhile, emerging hubs within the broader region are increasingly important for localized manufacturing and as markets for cost-effective, robust instruments that support expanding diagnostic capabilities.

Asia-Pacific combines rapid adoption of portable and scalable technologies with growing in-region manufacturing capacity and government-backed initiatives that prioritize digital health and medical device innovation. High-volume healthcare markets and expanding research investment create opportunities for both cost-efficient device strategies and premium, data-rich platforms that support large-scale studies. Across regions, local policy, reimbursement frameworks, and talent availability influence how quickly new modalities move from early adoption to routine clinical use, and these factors should inform strategic decisions about product configuration, pricing, and post-sales service models.

Company strategies and competitive differentiators focused on modular hardware, advanced analytics, integrated services, and partnerships that drive long-term institutional adoption

Companies operating in the brain mapping instrument space are differentiating along multiple vectors, including hardware modularity, software sophistication, and depth of service offerings. Leading-edge device suppliers focus on sensor performance, signal fidelity, and ergonomic design to reduce setup time and to support diverse study populations. Concurrently, software-focused providers emphasize reproducible pipelines, explainable machine learning, and interoperable data standards that ease integration with electronic health records and laboratory systems.

Service providers are enhancing their propositions by bundling consulting, validation, and training with long-term maintenance contracts that align incentives around uptime and data quality. Alliances between device manufacturers and cloud or analytics firms are increasingly common, reflecting a move toward platform-centric business models. Startups frequently introduce disruptive hardware concepts or specialized analytics, and incumbent firms respond through targeted acquisitions, strategic partnerships, or by accelerating internal development of complementary capabilities.

Investor attention and corporate development activity tend to favor companies that demonstrate regulatory acumen and the ability to deliver evidence of clinical or translational value. Firms that can show robust data governance frameworks, an ecosystem of clinical partners, and flexible delivery models-ranging from capital sales to subscription services-are better positioned to capture multi-stakeholder value. Finally, operational excellence in manufacturing, supply chain resilience, and customer support often determines long-term customer retention, especially in clinical and diagnostic settings where continuity of service is paramount.

Actionable recommendations for leaders to strengthen supply chains, invest in data platforms, and build collaborative evidence pathways that enable sustained clinical adoption

Industry leaders should prioritize supply chain resilience and modular product design to buffer against geopolitical and tariff-related disruptions, thereby ensuring continuity of service for clinical and research customers. Investing in localized assembly or strategic supplier partnerships can reduce lead-time volatility and protect institutions from sudden cost shocks, while modular hardware architectures enable incremental upgrades that extend device lifecycles and protect customer procurement budgets.

Leaders must also accelerate investment in data management and analysis platforms that support regulatory traceability and interoperable workflows. Emphasizing reproducible analysis pipelines, provenance tracking, and privacy-preserving data strategies will facilitate clinical adoption and partnerships with pharmaceutical research programs. Coupled with targeted service offerings-such as on-site training, remote maintenance, and outcome-oriented consulting-these capabilities can convert transactional relationships into strategic long-term engagements.

Strategic collaboration with academic centers and clinical leaders is essential to generate evidence of clinical utility and to co-develop protocols that align with payer and regulatory expectations. Companies should explore flexible commercial models, including subscription-based access and outcome-tied pricing, to lower adoption barriers for cash-constrained institutions. Finally, a focused regulatory strategy that anticipates cross-jurisdictional validation requirements will reduce time to deployment and minimize rework, particularly for organizations planning to localize manufacturing or to enter new regional markets.

A rigorous mixed-methods research methodology combining stakeholder interviews, regulatory review, and technology mapping to produce actionable and reproducible insights

The research methodology underpinning this executive summary integrates qualitative and structured evidence-gathering techniques to ensure robustness and relevance. Primary inputs include in-depth interviews with clinicians, research directors, procurement officers, and device engineers to capture operational realities, pain points, and adoption criteria. These insights are supplemented by a systematic review of regulatory guidance, technical standards, and peer-reviewed literature to map validation pathways, safety considerations, and methodological best practices.

Analytical processes involve technology-by-application mapping to align device capabilities with clinical and research requirements, as well as supply chain mapping to identify sourcing risks and mitigation opportunities. Triangulation across perspectives-end users, manufacturers, and service providers-helps to validate conclusions and to ensure that recommendations reflect real-world constraints. Care is taken to document assumptions and to disclose limitations where evidence is emerging or where regional heterogeneity affects generalizability.

Data governance for the study prioritizes traceability and reproducibility, with structured protocols for coding interview themes and for archiving primary sources. Where quantitative inputs inform scenario interpretation, conservative and transparent approaches are applied to avoid overstating certainty. The overall approach aims to balance depth of insight with practical applicability for decision-makers across clinical, research, and commercial functions.

A concise conclusion summarizing the interplay of technological innovation, service models, and supply chain dynamics that will shape the future of brain mapping instruments

The trajectory of brain mapping instruments is characterized by rapid technological advances, evolving service models, and shifting supply chain realities that together create both opportunity and complexity for stakeholders. Across hardware, software, and services, success increasingly depends on delivering interoperable, data-centric solutions that respect regulatory and clinical workflows while providing clear pathways to operational deployment. Adoption patterns reflect the interplay between high-fidelity modalities and emerging portable formats, and the most successful strategies weave these modalities into flexible, evidence-backed offerings.

Regional and policy dynamics, including trade policy adjustments, have underscored the importance of supply chain agility, localized validation, and service-led commercial models. Organizations that proactively address these dimensions through modular design, investment in data management, and collaborative evidence generation will be better placed to meet the diverse needs of academic researchers, clinical teams, and pharmaceutical developers. In sum, the most resilient and impactful players will be those that blend technical excellence with robust support structures and strategic partnerships that accelerate translation from research to clinical utility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of portable EEG systems for remote neurological diagnostics and continuous patient monitoring
  • 5.2. Integration of artificial intelligence algorithms with neuroimaging data to enhance brain mapping accuracy and predictive analytics
  • 5.3. Development of wearable brain monitoring devices using functional near infrared spectroscopy technology in clinical research
  • 5.4. Expansion of cloud based neuro data platforms for real time collaboration and big data analysis in neuroscience studies
  • 5.5. Regulatory approvals and reimbursement frameworks driving the commercialization of diagnostic brain mapping instruments in hospitals
  • 5.6. Rise of direct to consumer brain mapping headsets offering accessible cognitive performance insights and neurofeedback
  • 5.7. Advancements in multimodal brain mapping combining EEG, MEG, and MRI to improve spatial temporal resolution in research

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Brain Mapping Instruments Market, by Component

  • 8.1. Hardware
    • 8.1.1. Analysis Equipment
    • 8.1.2. Electrodes & Sensors
    • 8.1.3. Scanners
  • 8.2. Services
    • 8.2.1. Consulting
    • 8.2.2. Maintenance & Training
  • 8.3. Software
    • 8.3.1. Analysis Software
    • 8.3.2. Data Management Software

9. Brain Mapping Instruments Market, by Technology

  • 9.1. EEG
    • 9.1.1. Portable EEG Systems
    • 9.1.2. Stationary EEG Systems
    • 9.1.3. Wireless EEG Systems
  • 9.2. fMRI
    • 9.2.1. Clinical fMRI
    • 9.2.2. Research fMRI
  • 9.3. MEG
    • 9.3.1. Helmet-Based MEG
    • 9.3.2. Wearable MEG
  • 9.4. NIRS
    • 9.4.1. Continuous Wave NIRS
    • 9.4.2. Frequency Domain NIRS
    • 9.4.3. Time Domain NIRS
  • 9.5. PET
    • 9.5.1. Amyloid PET
    • 9.5.2. FDG-PET
    • 9.5.3. Tau PET

10. Brain Mapping Instruments Market, by Application

  • 10.1. Clinical
    • 10.1.1. Neurology
    • 10.1.2. Oncology
    • 10.1.3. Psychiatry
  • 10.2. Research
    • 10.2.1. Academic Research
    • 10.2.2. Cognitive Neuroscience
    • 10.2.3. Pharmaceutical Research

11. Brain Mapping Instruments Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Hospitals & Diagnostic Centers
  • 11.3. Pharmaceutical & Biotechnology Companies

12. Brain Mapping Instruments Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Brain Mapping Instruments Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Brain Mapping Instruments Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Advanced Brain Monitoring, Inc
    • 15.3.2. Brainlab AG
    • 15.3.3. Siemens Healthineers AG
    • 15.3.4. Shimadzu Corporation
    • 15.3.5. Nihon Kohden Corporation
    • 15.3.6. Medtronic PLC
    • 15.3.7. SCANCO Medical AG
    • 15.3.8. Koninklijke Philips N.V.
    • 15.3.9. Cognionics, Inc.
    • 15.3.10. GE Healthcare

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRAIN MAPPING INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BRAIN MAPPING INSTRUMENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BRAIN MAPPING INSTRUMENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTRODES & SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONSULTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAINTENANCE & TRAINING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ANALYSIS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PORTABLE EEG SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATIONARY EEG SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WIRELESS EEG SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL FMRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH FMRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HELMET-BASED MEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY WEARABLE MEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CONTINUOUS WAVE NIRS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FREQUENCY DOMAIN NIRS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TIME DOMAIN NIRS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY AMYLOID PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FDG-PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TAU PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PSYCHIATRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COGNITIVE NEUROSCIENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY EEG, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FMRI, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MEG, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY NIRS, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PET, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY CLINICAL, 2025-2032 (USD MILLION)
  • TABLE 295. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 296. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY SOFTW